Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers
The net effect is simple: After weight loss, people are hungrier, feel less satisfied after eating and burn fewer calories than expected
Absorbance was measured at 405 nm using a Sunrise Absorbance Microplate Reader (Tecan Group Ltd.)
In August 2024, we surveyed 23andMe research participants about their GLP1 medication usage, focusing on those taking weight loss medication
Modeling data suggest that loss of muscle mass varies by sex, representing 1015 % of total weight reduction in women and 2025 % of total weight reduction in men, in the absence of structured strength training [60]
One consequence of this popularity is that despite their high cost, the GLP-1 agonist medications have seen demand outstrip their supply resulting in shortages making their availability to treat diabetes more limited